The state body that pays for publicly funded health care in Latvia. It sends invitations for breast and cervical cancer screening, funds prostate screening and runs the national e-health system.
The Nacionālais veselības dienests administers Latvia's state-funded health care and, according to SPKC's reporting instructions, is the controller of the national e-health system. The OECD and European Commission's 2025 Country Cancer Profile describes it sending invitation letters for breast screening (women aged 50 to 69 every two years) and cervical screening (cytology at 25 and 28, primary HPV testing from 30 to 67), and sets out the copayments patients pay for cancer care: EUR 7 a day in hospital and EUR 0.71 per prescription for cancer drugs, with exemptions for children, low-income patients and palliative care. Its own site describes prostate screening as fully funded by the state; SPKC's notice describes it as a PSA blood test, and the profile gives it as every two years for men aged 50 to 75. SPKC's 2025 notice gives its 2023 screening uptake: 55.2% cervical, 36.1% breast, 25.8% bowel and 80% prostate; the profile says the prostate figure should be read with caution, because it counts all PSA tests in men aged 50 to 75 except those done for a cancer diagnosis.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/